[Gastric carcinoid tumors]
Related Experiment Video
Updated: Nov 1, 2026

Establishment and Evaluation of a Risk Prediction Model for Pathological Escalation of Gastric Low-Grade Intraepithelial Neoplasia
Published on: February 16, 2024
1Service d'hépato-gastro-entérologie Centre hospitalier de Villeneuve-Saint-Georges.
Abstract:
Gastric carcinoid tumors are divided up into three groups of various presentation and prognosis. Carcinoids tumors on fundic atrophic gastritis with achlorhydria resistant to pentagastrine stimulation, the most numerous, and those observed in patients with Zöllinger-Ellison syndrome, are fundic, readily small and numerous, of slow evolution with rare metastasis and without carcinoid syndrome. They are associated with an hypergastrinemia of antral or tumoral origin, responsible for a diffuse endocrin hyperplasia upon which they rest. The other carcinoid tumors, called sporadic, are usually unique and more voluminous, much more aggressive. They are accompanied by a carcinoid syndrome in one third of the cases. They occur without any hypergastrinemia and rest on a entirely normal gastric mucosa. The diagnosis of gastric carcinoid tumor imperatively requires an assessment intended to classify the tumors and to set up therapeutic indications.
Related Concept Videos
Gastritis II: Pathophysiology
Gastritis-I: Introduction and Types
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
Pyloric Obstruction
Barrett Esophagus-I: Introduction
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more similar...
Hormones Secreted by the Stomach
Each of these hormones secreted by different enteroendocrine cells plays a unique role in digestion. Here are a few examples:
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists